Skip to main content
SpringerLink
Log in

Increased bleeding, mortality with >1 year of DAPT post-stenting

  • Review
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. DAPT comprises aspirin and a purinoceptor P2Y12 antagonist.

References

  1. Palmerini T, et al. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials. Lancet : [12 pages], 14 Mar 2015. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(15)60263-X

  2. Curzen N. Prolonged antiplatelet therapy after drug-eluting stents. Lancet : [2 pages], 14 Mar 2015. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(15)60448-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Increased bleeding, mortality with >1 year of DAPT post-stenting. Reactions Weekly 1546, 8 (2015). https://doi.org/10.1007/s40278-015-9347-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-9347-0

Search

Navigation